Analytical Data
-
Gene name
C15orf29
- Application
-
Alternative Names
KATNBL1; C15orf29KATNB1-like Protein 1; Katanin p80 subunit B-like 1
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9H079
-
Expression Region
1-304aa
-
AA Sequence
MASETHNVKK RNFCNKIEDH FIDLPRKKIS NFTNKNMKEV KKSPKQLAAY INRTVGQTVK SPDKLRKVIY RRKKVHHPFP NPCYRKKQSP GSGGCDMANK ENELACAGHL PEKLHHDSRT YLVNSSDSGS SQTESPSSKY SGFFSEVSQD HETMAQVLFS RNMRLNVALT FWRKRSISEL VAYLLRIEDL GVVVDCLPVL TNCLQEEKQY ISLGCCVDLL PLVKSLLKSK FEEYVIVGLN WLQAVIKRWW SELSSKTEII NDGNIQILKQ QLSGLWEQEN HLTLVPGYTG NIAKDVDAYL LQLH
-
Molecular Weight
59.18 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C15orf29, also known as chromosome 15 open reading frame 29, is a gene located on chromosome 15 that has garnered interest in recent years due to its potential implications in various biological processes and diseases. Research indicates that C15orf29 may play a role in the regulation of cellular functions, including cell proliferation and differentiation. Its expression has been linked to certain developmental disorders and neurodegenerative diseases, highlighting the importance of understanding its function at the molecular level. The protein product of C15orf29 remains relatively understudied, with limited knowledge regarding its structure, interactions, and mechanisms of action. Recombinant protein technology offers a promising approach to investigate C15orf29, allowing researchers to produce and purify the protein for functional assays and structural analyses. By generating C15orf29 as a recombinant protein, scientists aim to uncover its biological role, elucidate its involvement in disease mechanisms, and assess its potential as a therapeutic target. This research could ultimately contribute to the development of novel strategies for diagnosing or treating conditions associated with C15orf29 dysfunction. As biotechnological tools and methods improve, the study of C15orf29 and its recombinant protein is expected to advance, providing deeper insights into its significance in health and disease.
